MediCardia Health Inc. has announced significant progress in its exclusive healthcare technologies, unveiling updates to its core software known as 'Co-Pilot.'

Satio is thrilled to share news of securing a contract from the Biomedical Advanced Research and Development Authority (BARDA), a division of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services.

Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a trailblazer in AI-powered precision cardiovascular medical tests, has proudly announced the successful culmination of a heart disease fair, sponsored by an employer, in Kansas, United States.

Azalea Health, a prominent provider of comprehensive cloud-based healthcare IT solutions and services, has joined forces with Particle Health, an intelligent data platform that aggregates and delivers actionable patient data and insights to healthcare entities.

C2N Diagnostics, a prominent player in advanced brain health diagnostics, has announced the launch of its new PrecivityAD2 blood test. This clinical care assay has been developed to meet the standard of care set by existing PET scans and cerebrospinal fluid tests.

Verily, a leading company in precision health technology under the Alphabet umbrella, and OneOncology, a prominent national platform supporting independent oncology practices, have joined forces in a strategic partnership aimed at optimizing the efficiency of clinical trials.

TransMedics Group, Inc., a pioneering medical technology firm dedicated to revolutionizing organ transplant therapy for individuals afflicted by end-stage lung, heart, and liver failure

Technology provider SONIFI Health has partnered with Tennessee-based healthcare system Williamson Health to implement technology solutions designed to empower patients with confidence, comfort and convenience.

Carle Health, a vertically integrated health system, today announced the deployment of UV-C air disinfection technology in partnership with R-Zero, a global leader in healthy buildings and green buildings. The rollout serves Carle Health's efforts to provide its patients, staff, and visitors with a clean, safe environment.

Sequel, a startup focused on improving health and wellness experiences for women, has announced that its innovative spiral tampon has received approval from the United States Food and Drug Administration (FDA) as a medical device.